|
Originally published In Press as doi:10.1074/jbc.M207531200 on October 9, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47796-47803, December 6, 2002
Subtype-specific Expression of Group III Metabotropic
Glutamate Receptors and Ca2+ Channels in Single Nerve
Terminals*
Carmelo
Millán ,
Rafael
Luján§,
Ryuichi
Shigemoto¶, and
José
Sánchez-Prieto
From the Departamento de Bioquímica, Facultad
de Veterinaria, Universidad Complutense, 28040 Madrid, Spain, the
§ Centro Regional de Investigaciones Biomédicas,
Facultad de Medicina, Universidad de Castilla-La Mancha, Campus de
Albacete, 02071 Albacete, Spain, and the ¶ National Institute for
Physiological Sciences, Myodaiji, Okazaki 444-8585, Japan
Received for publication, July 26, 2002, and in revised form, September 26, 2002
 |
ABSTRACT |
The release properties of glutamatergic
nerve terminals are influenced by a number of factors, including the
subtype of voltage-dependent calcium channel and the
presence of presynaptic autoreceptors. Group III metabotropic glutamate
receptors (mGluRs) mediate feedback inhibition of glutamate release by
inhibiting Ca2+ channel activity. By imaging
Ca2+ in preparations of cerebrocortical nerve terminals, we
show that voltage-dependent Ca2+ channels are
distributed in a heterogeneous manner in individual nerve terminals.
Presynaptic terminals contained only N-type (47.5%; conotoxin
GVIA-sensitive), P/Q-type (3.9%; agatoxin IVA-sensitive), or both N-
and P/Q-type (42.6%) Ca2+ channels, although the remainder
of the terminals (6.1%) were insensitive to these two toxins. In this
preparation, two mGluRs with high and low affinity for
L(+)-2-amino-4-phosphonobutyrate were identified by
immunocytochemistry as mGluR4 and mGluR7, respectively. These receptors
were responsible for 22.2 and 24.1% reduction of glutamate release,
and they reduced the Ca2+ response in 24.4 and 30.3% of
the nerve terminals, respectively. Interestingly, mGluR4 was largely
(73.7%) located in nerve terminals expressing both N- and P/Q-type
Ca2+ channels, whereas mGluR7 was predominantly (69.9%)
located in N-type Ca2+ channel-expressing terminals. This
specific coexpression of different group III mGluRs and
Ca2+ channels may endow synaptic terminals with distinct
release properties and reveals the existence of a high degree of
presynaptic heterogeneity.
 |
INTRODUCTION |
The release properties of presynaptic terminals are determined by
factors such as the presence of auto- or heteroreceptors, the subtype
of voltage-dependent Ca2+ channel coupled to
neurotransmitter release at the active zone, and the machinery of
synaptic vesicle fusion. Thus, it is possible to observe different
release properties among presynaptic terminals even when considering
terminals on the same axon as a consequence of a target cell-specific
distribution of presynaptic metabotropic glutamate receptors
(mGluRs)1 (1, 2). Group III
mGluRs expressed in the brain consist of three different subtypes
(mGluR4, mGluR7, and mGluR8) (for review, see Refs. 3 and 4) that are
localized within presynaptic active zones (1, 5, 6), where they act as
autoreceptors mediating the inhibition of glutamate release (7-10).
Although these receptors are also responsible for reducing cAMP levels (11-15), the inhibition of induced glutamate release is primarily mediated by the inhibition of Ca2+ channel activity (8, 10,
16-19).
Voltage-dependent Ca2+ channels are fundamental
components of the presynaptic release machinery whereby glutamate
release and hence synaptic strength can be modulated (20). Indeed, a
number of electrophysiological studies have shown that the release of glutamate depends primarily on the activity of P/Q- and N-type Ca2+ channels (21-25). These same electrophysiological
studies have suggested that Ca2+ channels exhibit a
heterogeneous distribution in glutamatergic nerve terminals, which may
express N- or P/Q-type calcium channels or a combination of both.
Because the Ca2+ channel profile may confer specific
release properties to glutamatergic nerve terminals, it is possible
that the distinct group III mGluRs are also restricted to
subpopulations of nerve terminals depending upon the type or
combination of Ca2+ channels present. However, due to the
small size of the synaptic boutons and because synaptic transmission
studies provide average measures of the release from a large number of
nerve terminals, the precise distribution of Ca2+ channels
in single nerve terminals remains largely unknown. It also remains to
be established whether presynaptic mGluRs are expressed in terminals
endowed with a particular subtype of Ca2+ channels.
In this study, by imaging Ca2+ in single nerve terminals,
we have established the distribution of Ca2+ channels and
group III mGluRs. In the cerebrocortical preparation of nerve terminals
from young rats, two mGluRs exhibiting high and low affinity for
L(+)-2-amino-4-phosphonobutyrate (L-AP4) and
immunocytochemically identified as mGluR4 and mGluR7, respectively, reduced the entry of Ca2+ and the release of glutamate in a
different subpopulation of terminals. Interestingly, we found that
mGluR4 was primarily located in terminals that coexpress N- and
P/Q-type Ca2+ channels, whereas mGluR7 was preferentially
expressed with N-type Ca2+ channels. This distinct
distribution of Ca2+ channel types in mGluR4- and
mGluR7-expressing nerve terminals may account for the terminal-specific
modulation of glutamate release through group III mGluRs. These data
demonstrate for the first time the selective distribution of two group
III mGluRs in a different population of Ca2+
channel-containing nerve terminals.
 |
EXPERIMENTAL PROCEDURES |
Synaptosomal Preparation--
Synaptosomes were purified on
discontinuous Percoll gradients (Amersham Biosciences, Uppsala, Sweden)
as previously described (26, 27). Briefly, cerebral cortices were
isolated from young male Wistar rats (3 weeks old) and homogenized in
medium containing 0.32 M sucrose (pH 7.4). The homogenate
was centrifuged at 2000 × g for 2 min at 4 °C, and
the supernatant was spun again at 9500 × g for 12 min.
From the pellets formed, the white loosely compacted layer containing
the majority of the synaptosomes was gently resuspended in 8 ml of 0.32 sucrose (pH 7.4). Of this synaptosomal suspension, 2 ml was placed onto
a 3-ml Percoll discontinuous gradient containing 0.32 M
sucrose; 1 mM EDTA; 0.25 mM
DL-dithiothreitol; and 3, 10, or 23% Percoll (pH 7.4).
After centrifugation at 25,000 × g for 10 min at
4 °C, the synaptosomes were recovered from between the 10 and 23%
Percoll bands and diluted in a final volume of 30 ml of HEPES buffer
medium (HBM) containing 140 mM NaCl, 5 mM KCl, 5 mM NaHCO3, 1.2 mM
NaH2PO4, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES (pH 7.4). Following
centrifugation at 22,000 × g for 10 min, the
synaptosomes were resuspended in 8 ml of HBM, and the protein content
was determined by the biuret method. Finally, 1 mg of the synaptosomal
suspension was diluted in 8 ml of HBM and spun at 3000 × g for 10 min. The supernatant was discarded, and the pellets
containing the synaptosomes were stored on ice. Under these conditions,
the synaptosomes remained fully viable for at least 4-6 h as judged by
the extent of KCl- and 4-aminopyridine-induced glutamate release.
Glutamate Release--
Glutamate release was assayed by on-line
fluorometry as described previously (28). Synaptosomal pellets were
resuspended in HBM (0.67 mg/ml) and preincubated at 37 °C for 1 h in the presence of 16 µM bovine serum albumin to bind
any free fatty acids released from synaptosomes during the
preincubation. A 1-ml aliquot was transferred to a stirred cuvette
containing 1 mM NADP+, 50 units of glutamate
dehydrogenase (Sigma), and 1.33 mM CaCl2 or 200 nM free Ca2+, and the fluorescence of NADPH was
followed in a PerkinElmer Life Sciences LS-50 luminescence spectrometer
at excitation and emission wavelengths of 340 and 460 nm, respectively.
Traces were calibrated by addition of 2 nmol of glutamate at the end of
each assay. Data points were obtained at 2-s intervals and corrected for Ca2+-independent release. Thus, the
Ca2+-dependent release was calculated by
subtracting the release obtained during a 5-min period of
depolarization at 200 nM free Ca2+ from the
release at 1.33 mM CaCl2.
Ca2+ Imaging: Ca2+ Responses in Single
Synaptosomes--
Synaptosomes in HBM (2 mg/ml) with 16 µM bovine serum albumin were preincubated with 5 µM fura-2/AM and 1.33 mM CaCl2
for 40 min. The synaptosomal suspension was attached to a
polylysine-coated coverslip for 1 h. A superfusion chamber was
carved in small Petri dish, which was mounted on a Nikon inverted stage
microscope. The medium was fed into the chamber by gravity at 1-1.5
ml/min from a prewarmed (37 °C) reservoir and continuously removed
by aspiration. Synaptosomes were illuminated alternately at 340 and 380 nm for 0.8 s through a ×100 objective with the aid of a
monochromator (Kinetic Imaging, Ltd.), and the fluorescence emitted
from the nerve terminals was collected through a band-pass filter
centered at 510 nm. The video images were obtained using a slow-scan
CCD camera (Hamamatsu C4880) operating at 12-bit digitalization (4096 levels), and the output from the camera was stored by a computerized imaging system (Kinetic Imaging, Ltd.). Individual synaptosomes were
visualized as bright round spots in fluorescence images. Background at F340 nm and
F380 nm was substracted from each series of
F340 nm and F380 nm
images. A binary mask constructed by local equalization and
thresholding of row images was applied to isolate round measuring
areas, zeroing pixels outside of the bright spots. Using this, some
synaptosomes were not analyzed, but never >5-10%. Ratio images were
stored as 32-bit floating point number data. The cytosolic free
[Ca2+] was derived from the
F340 nm/F380 nm ratio
with the equation derived by Grynkiewicz et al. (29) using
Lucida Version 3.0 (Kinetic Imaging, Ltd.).
Rmax, Rmin, and parameters were determined from in vitro calibration by
recording fluorescence from small droplets of fura-2 free acid
(Molecular Probes, Inc., Eugene, OR) dissolved in intracellular
solution containing 100 mM KCl, 10 mM NaCl, 1 mM MgCl2, 10 mM MOPS, and 10 µM fura-2 (pH 7.0) plus 2 mM
CaCl2 (saturated Ca2+) or 2 mM EGTA
(0 Ca2+). For cytosolic free [Ca2+]
measurements, synaptosomes were stimulated by 10-s pulses (indicated in
each graph by a bar) of 30 mM KCl in the absence
and presence of pharmacological agonists or antagonists. Drugs were
applied to the nerve terminals by switching the perfusion solution.
Antibody Controls--
The affinity-purified rabbit
polyclonal antibody against mGluR7a and the affinity-purified guinea
pig polyclonal antibodies against mGluR4a and mGluR8a used here have
been described elsewhere (6). The monoclonal anti-synaptophysin
antibody was obtained from Sigma. The rabbit polyclonal antibodies
against the vesicular glutamate transporters VGLUT1 and VGLUT2 were
obtained from Synaptic Systems (Göttingen, Germany). The rabbit
polyclonal anti-glutamate decarboxylase (GAD-65) antiserum were
purchased from Chemicon International, Inc. (Temecula, CA). To control
the immunochemical reaction, primary antibodies were omitted from the
staining procedure, whereupon no immunoreactivity resembling that
obtained using the specific antibodies could be detected.
Immunohistochemical Methods--
The synaptosomes were allowed
to attach to a polylysine-coated coverslip for 1 h and then fixed
for 5 min in 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4). Following several washes with 0.1 M phosphate
buffer (pH 7.4), the synaptosomes were preincubated in 10% normal goat
serum diluted in Tris-buffered saline (TBS; 50 mM Tris
buffer (pH 7.4) containing 0.9% NaCl) with 0.2% Triton X-100 for
1 h. They were then incubated for 24 h with the appropriate primary antiserum diluted in TBS with 1% normal goat serum and 0.2%
Triton X-100: mGluR7a (1 µg/ml), mGluR4a (1 µg/ml), mGluR8a (1 µg/ml), VGLUT1 (1:1000), VGLUT2 (1:1000), GAD-65 (1:1000), and
synaptophysin (1:1000). After washing with TBS, the synaptosomes were
incubated for 2 h with Cy2-coupled goat anti-rabbit or anti-mouse antibody or fluorescein-coupled donkey anti-guinea pig antibody. The
secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA) were diluted 1:200 in TBS. After several washes with TBS,
the coverslips were mounted with Fluoromount (Serva), and the
synaptosomes were viewed with a Nikon Diaphot microscope equipped with
a ×100 objective, a mercury lamp light source, and
fluorescein-rhodamine Nikon filter sets.
Chemicals--
-Conotoxin GVIA ( -CgTx) and -agatoxin
IVA ( -AgaTx) were supplied by Peptide Institute, Inc. (Osaka,
Japan). L-AP4 was from Tocris Cookson (Bristol, UK).
Fura-2/AM was from Molecular Probes, Inc. NADP+ and all
other reagents were from Sigma.
 |
RESULTS |
Responses to L-AP4 in Cerebrocortical Nerve Terminals
from Young Rats Are Mediated by mGluR4 and mGluR7--
The
depolarization elicited with 30 mM KCl in cerebrocortical
nerve terminals from young rats (3 weeks old) induced a
Ca2+-dependent release of 1.58 ± 0.02 nmol of glutamate/mg ± S.E. (n = 10). This
release was reduced by 22.2 ± 1.4% (n = 8) by
the group III mGluR agonist L-AP4 at 20 µM
and by 46.3 ± 1.3% (n = 8) when the agonist
concentration was increased to 1 mM (Fig. 1A). The inhibition of
glutamate release by L-AP4 followed a biphasic dose-response curve, with EC50 values of 1.37 and 371 µM, respectively. These data suggest that at least two
mGluRs are involved in the inhibition of glutamate release in this
preparation, one with a high and the second with a low affinity for
L-AP4 (Fig. 1B).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
mGluRs with high and low affinity for
L-AP4 inhibit glutamate release in cerebrocortical nerve
terminals. A, inhibition of glutamate release by
low and high concentrations of L-AP4. The
Ca2+-dependent release of glutamate was induced
by 30 mM KCl in the absence (Control;
n = 10) and presence (n = 8) of 20 µM and 1 mM L-AP4, added 30 s before depolarization of the nerve terminals. B,
concentration-response curve of L-AP4-induced
inhibition of glutamate release (n = 3). The mGluR
agonist was added 30 s prior to depolarization of nerve terminals
with 30 mM KCl. Data are means ± S.E. n
indicates the number of data averaged and the number of nerve terminal
preparations. div, division.
|
|
Because group III mGluR-mediated inhibition of induced glutamate
release is the consequence of a reduction in Ca2+ channel
activity (8, 10, 17, 19), Ca2+ imaging experiments were
performed to determine which subpopulation of nerve terminals expresses
these receptors. Immobilized fura-2-loaded nerve terminals were used to
determine the impact of activating group III mGluRs with respect to
calcium influx induced by depolarization at the level of a single nerve
terminal. A total of 2180 fura-2-loaded nerve terminals that responded
to KCl were analyzed from five separate fields similar to that shown in
Fig. 2A. Although the basal
cytosolic free [Ca2+] was 78.1 ± 3.0 nM
(n = 60), the responses to 10 s of depolarization with 30 mM KCl were transient, ranging from 500 to 800 nM. Nerve terminals expressing mGluRs with high and low
affinity for L-AP4 were distinguished by their responses to
applications of 20 µM and then 1 mM
L-AP4 in the presence of 30 mM KCl. A
subpopulation of nerve terminals (24.4 ± 1.2%) responded to 20 µM L-AP4 with a strong reduction of the
Ca2+ response (Fig. 2B), whereas another
subpopulation (30.3 ± 1.7%) responded only to the application of
1 mM L-AP4 (Fig. 2C). The viability
of the preparation was assessed by further addition of 30 mM KCl, which elicited a Ca2+ response
comparable to that produced by the first depolarization in the absence
of L-AP4. In addition, in 45.3 ± 1.0% of the
fura-2-loaded particles, L-AP4 did not alter the
Ca2+ responses (Fig. 2D), indicating that this
subpopulation of nerve terminals does not express functional
L-AP4-sensitive mGluRs.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Low and high concentrations of
L-AP4 reduce the Ca2+ responses of individual
nerve terminals in two different subpopulations. Synaptosomes were
fixed on polylysine-coated coverslips and loaded with fura-2 as
indicated under "Experimental Procedures." A,
representative field of fura-2-loaded synaptosomes under basal
conditions at 380 nm. Ca2+ responses were induced by a 10-s
application of 30 mM KCl in the absence and presence of 20 µM L-AP4 or 1 mM
L-AP4. B and C, individual responses
of the subpopulation of terminals that responded to 20 µM
(n = 6) and 1 mM (n = 8)
L-AP4, respectively. D, individual responses of
the subpopulation of terminals that did not respond to any
concentration of L-AP4 (n = 7). Data are
means ± S.E. n indicates the number of individual
responses averaged. The disc diagrams indicate the percent
of nerve terminals showing a given response. Scale bar = 10 µm in A. [Ca2+]cyt, cytosolic free
calcium concentration; div, division.
|
|
Immunocytochemical staining was performed to identify the mGluR that
might mediate the responses to L-AP4. Among the
L-AP4-sensitive receptors (mGluR4 and mGluR6-8), mGluR6 is
not expressed in the brain (11). Thus, only the distribution of mGluR4,
mGluR7, and mGluR8 and that of the vesicular protein synaptophysin was
examined by immunocytochemistry. In these experiments, a lower
concentration of nerve terminals was attached to the polylysine-coated
coverslips to facilitate visualization. Among the
synaptophysin-containing particles (589 particles from seven fields),
mGluR7 was detected in 29.5 ± 3.4% (mean ± S.E.) of the
terminals (Fig. 3, A-C). The mGluR4 protein was detected in 25.2 ± 2.8% of the
synaptophysin-containing particles (734 particles from seven fields)
(Fig. 3, D-F). In agreement with previous reports of the
restricted expression of mGluR8 in the cerebral cortex (30), mGluR8 was
found only in a small subpopulation (1.9 ± 0.6%) of
synaptophysin-containing nerve terminals (1578 particles from 11 fields) (Fig. 3, G-I). The mGluR4 and mGluR7 subtypes have
been shown to exhibit high (12) and low (13) affinity for
L-AP4, respectively, in modulating G protein-coupled
effectors. Thus, it is likely that these two mGluRs mediate the
majority of the responses to L-AP4 in cerebrocortical nerve
terminals from young rats.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
mGluR7, mGluR4, and mGluR8 are expressed in
the preparation of cerebrocortical synaptosomes.
Synaptosomes were fixed on polylysine-coated coverslips, and
images of double-stained nerve terminals were obtained by performing
immunocytochemistry with antisera against mGluR7, mGluR4, and mGluR8
and the vesicular marker synaptophysin. Antibody localization was
visualized with Cy3 filters for synaptophysin (A,
D, and G) and with fluorescein filters for
mGluR7, mGluR4, and mGluR8 (B, E, and
H, respectively). Merged panels are shown in C,
F, and I. Scale bar = 10 µm.
|
|
The finding that 20 µM L-AP4 inhibited the
release of glutamate by 22.2 ± 1.4% and the Ca2+
response in 24.4 ± 1.2% of the nerve terminal population
strongly suggests that most of the nerve terminals that respond to low concentrations of L-AP4 are glutamatergic. A similar
conclusion was reached when considering the mGluR with low affinity for
L-AP4 because at 1 mM, this agonist reduced the
release of glutamate by 24.1 ± 1.3% and the Ca2+
response in 30.3 ± 1.7% of the nerve terminals. To further study this possibility, synaptosomes were labeled with antiserum against the
vesicular protein synaptophysin, and glutamatergic nerve terminals were
identified with antisera against the vesicular glutamate transporters
VGLUT1 (31, 32) and VGLUT2 (33, 34). To identify GABAergic nerve
terminals, co-labeling was performed with synaptophysin and antiserum
against the GABA-synthesizing enzyme glutamate decarboxylase, GAD-65
(35). VGLUT1 was detected in 62.0 ± 3.3% (mean ± S.E.) of
the synaptophysin-containing particles (625 particles from 11 fields)
(Fig. 4, A-C). VGLUT2 was
present in 16.6 ± 2.2% of the synaptophysin-expressing particles
analyzed (319 particles from seven fields) (Fig. 4, D-F).
GAD-65 was detected in 23.0 ± 2.8% of a total of 304 particles
from six fields (Fig. 4, G-I). Because nerve terminals
coexpressing both VGLUT1 and VGLUT2 have not been found (36), we
concluded that ~80% of the nerve terminals in the synaptosomal
preparation were glutamatergic. These data are consistent with the
quantitative distribution of glutamatergic and GABAergic synapses in
the rodent cerebral cortex (37). Although our Ca2+ imaging
and glutamate release data suggest that most of the nerve terminals in
which L-AP4 alters the Ca2+ responses are
glutamatergic, It also seems likely that a proportion of nerve
terminals that respond to L-AP4 are GABAergic (38, 39).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Relative content of glutamatergic and
GABAergic nerve terminals in the synaptosomal preparation.
Synaptosomes were fixed on polylysine-coated coverslips, and images of
double-stained nerve terminals were obtained using antisera against the
vesicular glutamate transporters VGLUT1 and VGLUT2 and the
GABA-synthesizing enzyme GAD-65. Antiserum against synaptophysin was
used to label synaptic vesicles. Nerve terminals were visualized with
Cy3 filters for synaptophysin (A, D, and
G) and with Cy2 filters for VGLUT1, VGLUT2, and GAD-65
(B, E, and H, respectively). Merged
panels are shown in C, F, and I. Scale bar = 10 µm.
|
|
Heterogeneity of Ca2+ Channels in Cerebrocortical Nerve
Terminals from Young Rats--
In a number of studies of synaptic
transmission in which Ca2+ channel blockers have been
employed, the non-uniform distribution of the Ca2+ channels
appears to be associated with glutamate release (21-25). However, only
one study has addressed the heterogeneous distribution of
Ca2+ channels at the level of single presynaptic terminals
from rat hippocampal cells in culture (40). Because Ca2+
channels are key elements of the release machinery, and subpopulations of nerve terminals with different release properties express group III
mGluRs (2), it is likely that different subtypes of group III mGluRs
might be located in nerve terminals that contain different Ca2+ channels. To study this possibility, we first
performed Ca2+ imaging experiments to determine which types
of Ca2+ channels are expressed in the nerve terminals.
Fixed fura-2-loaded nerve terminals were depolarized with 30 mM KCl in the absence and presence of -CgTx (41) and
-AgaTx (22), selective inhibitors of N- and P/Q-type
voltage-dependent Ca2+ channels, respectively.
In total, 1644 fura-2-loaded particles from four fields were analyzed,
from which four different types of responses were obtained. In a
subpopulation of nerve terminals (47.5 ± 2.0%), the
Ca2+ response was strongly reduced by -CgTx (2 µM), but not by -AgaTx (200 nM) (Fig.
5A), indicating the presence
of N-type Ca2+ channels alone. In a second subpopulation
(42.6 ± 1.1%), inhibition was observed following exposure to
both toxins (Fig. 5B). In this population, although either
toxin alone reduced the Ca2+ significantly, a stronger
reduction was observed when the two toxins were applied together, clear
evidence for the coexistence of N- and P/Q-type Ca2+
channels in these terminals. A small subpopulation of nerve terminals (3.9 ± 2.0%) expressed only P/Q-type Ca2+ channels
as indicated by the ability of -AgaTx to reduce the Ca2+
response (Fig. 5C). Finally, in 6.1 ± 2.5% of the
nerve terminals, the Ca2+ response was resistant to both
toxins (Fig. 5D).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Inhibition of the KCl-induced
Ca2+ responses by specific Ca2+ channel
toxins. Ca2+ responses induced by 30 mM
KCl were determined in the presence of 200 nM -AgaTx
( -Aga-IVA), 2 µM -CgTx
( -CgT-GVIA), and a combination of both toxins. Control
Ca2+ responses were induced by 30 mM KCl in the
absence of toxins at the end of the experiment. A,
individual responses of the subpopulation of nerve terminals that
responded only to -CgTx (n = 5); B,
individual responses of the subpopulation of nerve terminals that
responded to both -AgaTx and -CgTx (n = 8);
C, individual responses of the subpopulation of nerve
terminals that responded only to -AgaTx (n = 6);
D, individual responses of the subpopulation of nerve
terminals that did not respond to any of the Ca2+ channel
toxins (n = 6). Data are means ± S.E.
n indicates the number of individual responses averaged. The
disc diagrams indicate the percent of nerve terminals
showing a given response.
[Ca2+]cyt, cytosolic free
calcium concentration; div, division.
|
|
In another set of experiments in which 1526 fura-2-loaded particles
from three fields were analyzed, we established that cerebrocortical nerve terminals were largely insensitive (95.5 ± 0.6%) to the L-type channel blocker nifedipine (10 µM) (Fig.
6A). In the remaining 4.5 ± 0.6% of the nerve terminals, the Ca2+ response was
inhibited by blocking these channels (Fig. 6B). However, the
KCl-induced Ca2+ response was completely abolished by the
nonspecific Ca2+ channel blocker Cd2+ (30 µM) in all nerve terminals (Fig. 6, A and
B).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
KCl-induced Ca2+ responses are
largely insensitive to nifedipine, but are blocked by
Cd2+. Ca2+ responses induced by 30 mM KCl were determined in the presence of 10 µM nifedipine (Nif.) and 30 µM
CdCl2. Control Ca2+ responses were induced by
30 mM KCl in the absence of inhibitors at the end of the
experiment. A, individual responses of the subpopulation of
nerve terminals insensitive to nifedipine (n = 8);
B, individual responses of the subpopulation of nerve
terminals responding to nifedipine (n = 6). Data are
means ± S.E. n indicates the number of individual
responses averaged. The disc diagrams indicate the percent
of nerve terminals showing a given response.
[Ca2+]cyt, cytosolic free
calcium concentration; div, division.
|
|
Both mGluR4 and mGluR7 Are Coexpressed with Different
Ca2+ Channels--
We next set out to determine whether
mGluRs with different affinities for L-AP4 are
preferentially distributed in any of these subpopulations of nerve
terminals or whether they are randomly distributed. To this end, nerve
terminals were stimulated with 30 mM KCl in the presence of
20 µM L-AP4, 1 mM
L-AP4, 2 µM -CgTx, or 200 nM
-AgaTx. In these experiments, 3074 fura-2-loaded particles from six
fields were analyzed. mGluRs with low affinity for L-AP4 were found largely (69.9 ± 1.5%) in N-type Ca2+
channel-expressing nerve terminals (Fig.
7A) and to a lesser extent
(30.1 ± 1.5%) in nerve terminals endowed with N- and P/Q-type Ca2+ channels (Fig. 7B). Co-localization of
mGluRs with low affinity for L-AP4 and P/Q-type
Ca2+ channels was very rarely observed (2 out of 3074 particles) (data not shown). In contrast, mGluRs sensitive to 20 µM L-AP4 were primarily expressed (73.7 ± 1.4%) in nerve terminals exhibiting both N- and P/Q-type calcium
channels (Fig. 8A). In these
terminals, L-AP4 reduced the Ca2+ response
further than exposure to either of the toxins alone, indicating that
the mGluR inhibited both types of Ca2+ channels. In the
remaining terminals sensitive to 20 µM L-AP4 (26.3 ± 1.4%), only N-type Ca2+ channels were found
(Fig. 8B). We did not detect any response to 20 µM L-AP4 in P/Q-type Ca2+
channel-containing nerve terminals.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Inhibition of the KCl-induced
Ca2+ responses by high concentrations of L-AP4
and Ca2+ channel toxins. Ca2+ responses
were determined in the presence of 20 µM or 1 mM L-AP4, 200 nM -AgaTx
( -Aga-IVA), or 2 µM -CgTx
( -CgT-GVIA). Control Ca2+ responses were
induced by 30 mM KCl in the absence of toxins at the end of
the experiment. A, individual responses of the subpopulation
of nerve terminals that responded to 1 mM L-AP4
and 2 µM -CgTx (n = 8); B,
individual responses of the subpopulation of nerve terminals that
responded to 1 mM L-AP4, 200 nM
-AgaTx, and 2 µM -CgTx (n = 6).
Data are means ± S.E. n indicates the number of
individual responses averaged. The disc diagrams indicate
the percent of nerve terminals showing a given response.
[Ca2+]cyt, cytosolic free
calcium concentration; div, division.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 8.
Inhibition of the KCl-induced
Ca2+ responses by low concentrations of L-AP4
and Ca2+ channel toxins. Ca2+ responses
were determined in the presence of 20 µM or 1 mM L-AP4, 200 nM -AgaTx
( -Aga-IVA), or 2 µM -CgTx
( -CgT-GVIA). Control Ca2+ responses were
induced by 30 mM KCl in the absence of toxins at the end of
the experiment. A, individual responses of the subpopulation
of nerve terminals that responded to 20 µM
L-AP4, 2 µM -CgTx, and 200 nM
-AgaTx (n = 6); B, individual responses
of the subpopulation of nerve terminals that responded to 20 µM L-AP4 and 2 µM -CgTx
(n = 6). Data are means ± S.E. n
indicates the number of individual responses averaged. The disc
diagrams indicate the percent of nerve terminals showing a given
response. [Ca2+]cyt, cytosolic
free calcium concentration; div, division.
|
|
 |
DISCUSSION |
By combining Ca2+ imaging and immunocytochemistry from
single nerve terminals with techniques to determine the release of
glutamate from a population of cerebrocortical nerve terminals, we have identified the mGluRs that mediate L-AP4 responses in this
preparation and the types of Ca2+ channels with which these
receptors might interact. Inhibition of glutamate release was largely
mediated by mGluR4 and mGluR7 as a result of reduction in the activity
of N- and P/Q-type Ca2+ channels, which were
heterogeneously distributed in the nerve terminals. Interestingly,
mGluR4 was predominantly located in terminals containing both N- and
P/Q-type Ca2+ channels, whereas mGluR7 was primarily
expressed in terminals containing only N-type Ca2+ channels.
mGluR4 and mGluR7 Mediate Release Inhibition in
Cerebrocortical Glutamatergic Terminals from Young Rats--
Because
mGluR6 is absent in the brain (11), we studied the immunocytochemical
distribution of mGluR4, mGluR7, and mGluR8 to identify the receptors
mediating the responses to L-AP4. The presence of mGluR4
and mGluR7 in cerebrocortical nerve terminals is consistent with the
expression of these two proteins in rat cerebral cortex (39, 42-44).
Moreover, mGluR4 and mGluR7 have been shown to exhibit high and low
affinity, respectively, for L-AP4 and glutamate in
modulating G protein-coupled effectors (12, 13). Thus, we conclude that
mGluR4 mediates the responses to low concentrations of
L-AP4, whereas mGluR7 will respond to only high
concentrations of this mGluR agonist. It is also possible that some
responses to low L-AP4 concentrations are mediated by mGluR8. However, this receptor was detected only in a minor
subpopulation of nerve terminals (1.9 ± 0.6%), consistent with
the restricted expression of mGluR8 that has been described in the
piriform cortex (30).
It is important to note that the immunocytochemical data nicely
correlate with data obtained in Ca2+ imaging experiments.
Thus, for example, mGluR7 was detected in 29.5 ± 3.4% of the
synaptophysin-positive particles, whereas this same receptor reduced
the Ca2+ responses in 30.3 ± 1.7% of the nerve
terminals. This would indicate, first, that most of the
mGluR7-containing nerve terminals are functional and, second, that
mGluR7 reduces the activity of Ca2+ channels in the
majority of such terminals. However, immunocytochemical and
Ca2+ imaging data do not provide a direct estimate of the
fraction of glutamatergic nerve terminals that contain mGluR7 because
both techniques detect the receptor both in glutamatergic and GABAergic nerve terminals. Nevertheless, when we consider that 1 mM
L-AP4 reduced glutamate release by 24.1%, and taking into
account the relative abundance of glutamatergic over GABAergic
terminals in this preparation, it would appear that mGluR7 is
predominantly, but not exclusively, expressed in glutamatergic
terminals (43). Indeed, both mGluR4 and mGluR7 have also been found in
GABAergic nerve terminals (38, 39). However, mGluR8 does not
co-localize with GAD-65,2
although it is expressed in glutamatergic terminals from the piriform
cortex (30).
Ca2+ Channel Heterogeneity in Cerebrocortical Nerve
Terminals--
Based on the supra-additive inhibition of synaptic
transmission caused by the different Ca2+ channel toxins, a
non-uniform distribution of Ca2+ channels in nerve
terminals has been anticipated (21-25). Directly quantifying this
heterogeneity has been limited by the fact that electrophysiological
recordings normally represent the averaged responses of many synapses,
particularly if the field excitatory postsynaptic potential is
measured. However, it is necessary to establish the precise
distribution of Ca2+ channels within nerve terminals to
understand synaptic function. In this study, by directly measuring the
Ca2+ responses from single cerebrocortical nerve terminals,
we have described a heterogeneous distribution of Ca2+
channels. Two major subpopulations of nerve terminals containing either
N-type (47.5%) or a combination of N- and P/Q-type (42.6%) Ca2+ channels were identified, as well as two minor
subpopulations of terminals containing either P/Q-type calcium channels
(3.9%) or calcium channels insensitive to -CgTx and -AgaTx
(6.1%). It is unlikely that this non-uniform distribution of
Ca2+ channels observed in the cerebrocortical preparation
is the result of differential expression of Ca2+ channel
subtypes in neuronal populations because a heterogeneous distribution
of Ca2+ channels has also been observed in single
hippocampal neurons (24, 40). It therefore seems that the heterogeneous
pattern for Ca2+ channel distribution is a widespread
phenomenon. It is important to note that our results are remarkably
similar to those found by Reuter (40), despite the presumably greater
anatomical heterogeneity of the cerebrocortical nerve terminal
preparation compared with hippocampal cell cultures. In that study, the
exocytosis (measured with the fluorescent dye FM1-43) was completely
inhibited by -CgTx in 45% of the boutons, whereas in the remaining
boutons, exocytosis was sensitive to a combination of -CgTx,
-AgaTx, and the L-type Ca2+ channel blocker
isradipine. In contrast, Reid et al. (24) found that
45% of the nerve terminals expressed only -AgaTx-sensitive Ca2+ channels in cultured hippocampal neurons. It is
important to note the age differences between the cultures used in
these two studies (24, 40); and thus, the different results could well be due to developmental changes in the distribution of Ca2+
channels (45). In the calix-type rat medial nucleus of the trapezoid body, P/Q-, N-, and R-type Ca2+ channels coexist
at individual release sites (46).
Although the functional implications of a non-uniform distribution of
Ca2+ channels are unknown, it is likely that this
heterogeneous distribution of Ca2+ channels could
contribute to different release properties of the terminals. In this
respect, a number of factors related to Ca2+ channel
function can influence release, including the biophysical properties of
individual Ca2+ channels, Ca2+ channel density
at the release site, and the efficiency with which the Ca2+
channels trigger exocytosis (25). In addition, an obvious advantage of
having more than one Ca2+ channel type in a nerve terminal
is the differential regulation of these channels by neuromodulators,
including those acting on G protein-coupled receptors, that can
generate a terminal-specific modulation of synaptic transmission.
mGluR7 and mGluR4 Are Selectively Located in Different Populations
of Ca2+ Channel-containing Nerve Terminals--
By
measuring the Ca2+ responses of single nerve terminals when
exposed to Ca2+ channel toxins and the agonist
L-AP4, we found that the low affinity L-AP4-sensitive mGluR7 is largely (70%) located in N-type
Ca2+ channel-expressing terminals, whereas the high
affinity L-AP4-sensitive mGluR4 is largely (74%) located
in N- and P/Q-type Ca2+ channel-expressing terminals. These
results reveal the existence of a high level of heterogeneity
among the L-AP4-sensitive mGluR-containing terminals. Thus,
by simply considering the distribution of mGluR4 and mGluR7 in N-type
and N- and P/Q-type Ca2+ channel-expressing terminals, six
different subpopulations of nerve terminals can be described: N-type
Ca2+ channel-expressing terminals with or without mGluR4 or
mGluR7 and N- and P/Q-type Ca2+ channel-expressing
terminals with or without mGluR4 or mGluR7. Although it is likely that
the preparation of cerebrocortical synaptosomes might contain terminals
from different anatomical locations, heterogeneity of group III mGluRs
has previously been shown even among the nerve terminals from the same
axon (2). An obvious functional advantage of this presynaptic
heterogeneity can be seen in the different release properties exhibited
by the terminal dependent on the target cell. We do not have an
explanation for the preferential location of mGluR7 in N-type
Ca2+ channel-expressing terminals and of mGluR4 in N- and
P/Q-type Ca2+ channel-expressing terminals because the
functional properties of these different cortical synapses are not
known. However, the role of these two receptors should be influenced,
at least in part, by their different affinities for glutamate (12, 13). Thus, although both receptors function in reducing glutamate release (10, 19), the remarkable differences in their affinities for glutamate
should determine their activation properties. The low affinity of
mGluR7 for glutamate may restrict its activation to the arrival of
action potentials at high frequency. However, two different situations
have to be considered for the mGluRs with high affinity for
L-AP4. If they are not activated under basal conditions,
then the release of glutamate induced by the arrival of an action
potential should depress the release induced by a subsequent action
potential. In contrast, if these receptors are tonically
activated under basal conditions (47), then the arrival of consecutive
action potentials would overcome the depression of Ca2+
channels with the subsequent facilitation of glutamate release. In this
regard, it is important to note that N- and P/Q-type Ca2+
channels also exhibit differences in voltage-dependent
facilitation (48). Further work is needed to understand the release
properties of the many group III mGluR-containing synapses.
 |
ACKNOWLEDGEMENT |
We thank M. Sefton for editorial assistance.
 |
FOOTNOTES |
*
This work was supported by Ministerio de Ciencia y
Tecnologia Grant BFI2001-1436 and Dirección General de
Investigación de la Comunidad de Madrid Grant 08.5/0075.1/2000
(to J. S.-P.) and European Community Grant QLG3-CT-1999-00192 (to
R. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
34-91-394-3891; Fax: 34-91-394-3909; E-mail:
jsprieto@vet.ucm.es.
Published, JBC Papers in Press, October 9, 2002, DOI 10.1074/jbc.M207531200
2
C. Millán, R. Luján, R. Shigemoto,
and J. Sánchez-Prieto, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
mGluRs, metabotropic
glutamate receptors, L-AP4,
L(+)-2-amino-4-phosphonobutyrate;
HBM, HEPES buffer medium;
MOPS, 4-morpholinepropanesulfonic acid;
TBS, Tris-buffered saline;
-CgTx, -conotoxin GVIA;
-AgaTx, -agatoxin IVA;
GABA, -aminobutyric acid.
 |
REFERENCES |
| 1.
|
Shigemoto, R.,
Kulik, A.,
Robert, J. D. B.,
Ohishi, H.,
Nusser, Z.,
Kaneko, T.,
and Somogy, P.
(1996)
Nature
381,
523-525[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Scanziani, M.,
Gahwiler, B.,
and Charpak, S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12004-12009[Abstract/Free Full Text]
|
| 3.
|
Pin, J.-P.,
and Duvoisin, R.
(1995)
Neuropharmacology
34,
1-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Conn, P. J.,
and Pin, J.-P.
(1997)
Annu. Rev. Pharmacol. Toxicol.
37,
205-237[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Bradley, S. R.,
Levey, A. I.,
Hersch, S. M.,
and Conn, P. J.
(1996)
J. Neurosci.
16,
2044-2056[Abstract/Free Full Text]
|
| 6.
|
Shigemoto, R.,
Kinoshita, A.,
Wada, E.,
Nomura, S.,
Ohishi, H.,
Takada, M.,
Flor, P. J.,
Neki, A.,
Abe, T.,
Nakanishi, S.,
and Mizuno, N.
(1997)
J. Neurosci.
17,
7503-7522[Abstract/Free Full Text]
|
| 7.
|
Forsythe, I. D.,
and Clements, J. D.
(1990)
J. Physiol. (Lond.)
429,
1-16[Abstract/Free Full Text]
|
| 8.
|
Trombley, P. Q.,
and Westbrook, G. L.
(1992)
J. Neurosci.
12,
2043-2050[Abstract]
|
| 9.
|
Gereau, R. W., IV,
and Conn, P. J.
(1995)
J. Neurosci.
15,
6879-6889[Abstract/Free Full Text]
|
| 10.
|
Herrero, I.,
Vázquez, E.,
Miras-Portugal, M. T.,
and Sánchez-Prieto, J.
(1996)
Eur. J. Neurosci.
8,
700-709[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Nakajima, Y.,
Iwakabe, H.,
Azawa, C.,
Nawa, H.,
Shigemoto, R.,
Mizuno, N.,
and Nakanishi, S.
(1993)
J. Biol. Chem.
268,
11868-11873[Abstract/Free Full Text]
|
| 12.
|
Tanabe, Y.,
Nomura, A.,
Masu, M.,
Shigemoto, R.,
Mizuno, N.,
and Nakanishi, S.
(1993)
J. Neurosci.
13,
1372-1378[Abstract]
|
| 13.
|
Okamoto, N.,
Hori, S.,
Akazawa, C.,
Hayashi, Y.,
Shigemoto, R.,
Mizuno, N.,
and Nakanishi, S.
(1994)
J. Biol. Chem.
269,
1231-1236[Abstract/Free Full Text]
|
| 14.
|
Saugstad, J. A.,
Kinzie, J. M.,
Mulvihill, E. R.,
Segerson, T. P.,
and Westbrook, G. L.
(1994)
Mol. Pharmacol.
45,
367-372[Abstract]
|
| 15.
|
Duvoisin, R. M.,
Zhang, C.,
and Ramonell, K.
(1995)
J. Neurosci.
15,
3075-3083[Abstract]
|
| 16.
|
Sahara, Y.,
and Westbrook, G. L.
(1993)
J. Neurosci.
13,
3041-3050[Abstract]
|
| 17.
|
Takahashi, T.,
Forsythe, I. D.,
Tsujimoto, T.,
Barnes-Davies, M.,
and Onodera, K.
(1996)
Science
274,
594-597[Abstract/Free Full Text]
|
| 18.
|
Vázquez, E.,
and Sánchez-Prieto, J.
(1997)
Eur. J. Neurosci.
9,
2009-2018[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Millán, C.,
Luján, R.,
Shigemoto, R.,
and Sánchez-Prieto, J.
(2002)
J. Biol. Chem.
277,
14092-14101[Abstract/Free Full Text]
|
| 20.
|
Hille, B.
(1994)
Trends Neurosci.
17,
531-535[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Luebke, J. I.,
Dunlap, K.,
and Turner, T.
(1993)
Neuron
11,
895-902[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Mintz, I. M.,
Sabatini, B. L.,
and Regehr, W. G.
(1995)
Neuron
15,
675-688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Wheeler, D. B.,
Randall, A.,
and Tsien, R. W.
(1996)
J. Neurosci.
16,
2226-2237[Abstract/Free Full Text]
|
| 24.
|
Reid, C. A.,
Clements, J. D.,
and Bekkers, J. M.
(1997)
J. Neurosci.
17,
2738-2745[Abstract/Free Full Text]
|
| 25.
|
Qian, J.,
and Noebels, J. L.
(2001)
J. Neurosci.
21,
3721-3728[Abstract/Free Full Text]
|
| 26.
|
Dunkley, P. R.,
Jarvie, P. E.,
Heath, J. W.,
Kidd, G. J. E.,
and Rostas, J. A. P.
(1986)
Brain Res.
372,
115-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Wang, J. K. T.,
Walaas, S. I.,
Sihra, T. S.,
Aderem, A.,
and Greengard, P.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2253-2256[Abstract/Free Full Text]
|
| 28.
|
Nicholls, D. G.,
Sihra, T. S.,
and Sánchez-Prieto, J.
(1987)
J. Neurochem.
49,
50-57[Medline]
[Order article via Infotrieve]
|
| 29.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 30.
|
Kinoshita, A.,
Ohishi, H.,
Neki, A.,
Nomura, S.,
Shigemoto, R.,
Takada, M.,
Nakanishi, S.,
and Mizuno, N.
(1996)
Neurosci. Lett.
207,
61-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Takamori, S.,
Rhee, J. S.,
Rosenmund, C.,
and Jahn, R.
(2000)
Nature
497,
189-194
|
| 32.
|
Bellocchio, E. E.,
Reimer, R. J.,
Fremeau, R. T., Jr.,
and Edwards, R. H.
(2000)
Science
289,
957-960[Abstract/Free Full Text]
|
| 33.
|
Fremeau, R. T., Jr.,
Troyer, M. D.,
Pahner, I.,
Nygaard, G. O.,
Tran, C. H.,
Reimer, R. J.,
Bellocchio, E. E.,
Fortin, D.,
Storm-Mathisen, J.,
and Edwards, R. H.
(2001)
Neuron
31,
247-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Takamori, S.,
Rhee, J. S.,
Rosenmund, C.,
and Jahn, R.
(2001)
J. Neurosci.
21,
RC182[Abstract/Free Full Text], 1-6
|
| 35.
|
Kaufman, D. L.,
Houser, C. R.,
and Tobin, A. J.
(1991)
J. Neurochem.
56,
720-723[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Herzog, E.,
Bellenchi, G. C.,
Gras, C.,
Bernard, V.,
Ravassard, P.,
Bedet, C.,
Gasnier, B.,
Giros, B.,
and El Mestikawy, S.
(2001)
J. Neurosci.
21,
RC181[Abstract/Free Full Text], 1-6
|
| 37.
|
Somogyi, P.,
Tamás, G.,
Luján, R.,
and Buhl, E. H.
(1998)
Brain Res. Rev.
26,
113-135[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
| Luján, R., Shigemoto, R., and Somogyi, P. (1998) Eur.
J. Neurosci. 10, Suppl. 128, (Abstr.
54.16)
|
| 39.
|
Corti, C.,
Aldegheri, L.,
Somogyi, P.,
and Ferraguti, F.
(2002)
Neuroscience
110,
403-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Reuter, H.
(1995)
Neuron
14,
773-779[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Olivera, B. M.,
Gray, W. R.,
Zeikus, R.,
Mcintosh, J. M.,
Varga, J.,
River, J.,
Santos, V.,
and Cruz, L. J.
(1985)
Science
230,
1338-1343[Abstract/Free Full Text]
|
| 42.
|
Ohishi, H.,
Akazawa, C.,
Shigemoto, R.,
Nakanishi, S.,
and Mizuno, N.
(1995)
J. Comp. Neurol.
360,
555-570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Kinoshita, A.,
Shigemoto, R.,
Ohishi, H.,
Van der Putten, H.,
and Mizuno, N.
(1998)
J. Comp. Neurol.
393,
332-352[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Bradley, S. R.,
Rees, H. D., Yi, H.,
Levey, A. I.,
and Conn, P. J.
(1998)
J. Neurochem.
71,
636-641[Medline]
[Order article via Infotrieve]
|
| 45.
|
Scholtz, K. P.,
and Miller, R. J.
(1995)
J. Neurosci.
15,
4612-4617[Abstract]
|
| 46.
|
Wu, L.-G.,
Westenbroek, R. E.,
Borst, J. G. G.,
Catteral, W. A.,
and Sakmann, B.
(1999)
J. Neurosci.
19,
726-736[Abstract/Free Full Text]
|
| 47.
|
Pekhletski, R.,
Gerlai, R.,
Overstreet, L. S.,
Huang, X.-P.,
Agopyan, N.,
Slater, N. T.,
Abramow-Newerly, W.,
Roder, J. C.,
and Hampson, D. R.
(1996)
J. Neurosci.
16,
6364-6373[Abstract/Free Full Text]
|
| 48.
|
Herlitze, S.,
Zhong, H.,
Scheuer, T.,
and Caterall, W. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4699-4704[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Ferraguti, L. Crepaldi, and F. Nicoletti
Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives
Pharmacol. Rev.,
December 1, 2008;
60(4):
536 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Niswender, K. A. Johnson, Q. Luo, J. E. Ayala, C. Kim, P. J. Conn, and C. D. Weaver
A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors
Mol. Pharmacol.,
April 1, 2008;
73(4):
1213 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Rusakov, A. Wuerz, and D. M. Kullmann
Heterogeneity and Specificity of Presynaptic Ca2+ Current Modulation by mGluRs at Individual Hippocampal Synapses
Cereb Cortex,
July 1, 2004;
14(7):
748 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Millan, E. Castro, M. Torres, R. Shigemoto, and J. Sanchez-Prieto
Co-expression of Metabotropic Glutamate Receptor 7 and N-type Ca2+ Channels in Single Cerebrocortical Nerve Terminals of Adult Rats
J. Biol. Chem.,
June 20, 2003;
278(26):
23955 - 23962.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|